Taken together, these findings indicate that DNMT3A and GMPS exert context-dependent effects that are closely linked to the TME and immunogenomic landscape of each tumor type, emphasizing their potential as biomarkers for patient stratification and precision immuno-metabolic therapies. Here, GMPS is linked to neoplasm.